 TORRANCE, Calif. and PALO ALTO, Calif., April 13, 2021 GLOBE NEWSWIRE -- BridgeBio Pharma, Inc. NASDAQ: BBIO and The Lundquist Institute for Biomedical Innovation at the Harbor-UCLA Medical Center today announced a collaboration to translate research in genetically driven diseases and cancers into potential treatments for patients. 